Robeauté Bets on Rice-Sized Microrobots for Brain Disease

The CEO of French neurotechnology startup Robeauté says its microrobot could unlock precise delivery of drugs and other therapies directly into the brain, The microrobots, which are each the size of grain of rice, are able to reach areas that are difficult to access with existing treatments. Joana Cartocci says the company is targeting first-in-human studies in 2027 and a market launch in the early 2030s. She spoke to Tom Mackenzie on the latest episode of Bloomberg Tech: Europe. (Source: Bloomberg)